HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo G Tocchetti Selected Research

Carlo G Tocchetti Research Topics

Disease

28Cardiotoxicity
06/2021 - 02/2012
26Heart Failure
01/2023 - 01/2005
24Neoplasms (Cancer)
01/2022 - 02/2012
8Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2005
7Left Ventricular Dysfunction
01/2022 - 12/2011
5Myocarditis (Carditis)
01/2021 - 01/2019
5Cardiomyopathies (Cardiomyopathy)
01/2020 - 02/2012
4Hypertension (High Blood Pressure)
01/2022 - 01/2015
4Hypertrophy
01/2022 - 05/2008
4Fibrosis (Cirrhosis)
01/2020 - 05/2008
3Inflammation (Inflammations)
01/2022 - 05/2016
3Heart Block
11/2020 - 01/2019
3Cardiogenic Shock
11/2020 - 01/2019
3Myocardial Ischemia (Ischemic Heart Diseases)
05/2016 - 01/2015
2Reperfusion Injury
02/2022 - 02/2007
2Infarction (Infarctions)
02/2022 - 01/2015
2Heart Arrest (Cardiac Arrest)
01/2020 - 01/2019
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2018 - 01/2018
2Cardiomegaly (Heart Hypertrophy)
01/2018 - 05/2008
2Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 01/2018
2Mitochondrial Diseases (Mitochondrial Disease)
06/2016 - 06/2015
2Leukemia
05/2016 - 05/2016
2Thrombosis (Thrombus)
05/2016 - 05/2016
2Cardiac Arrhythmias (Arrythmia)
09/2014 - 04/2013
1Ischemia
02/2022
1Cystic Fibrosis (Mucoviscidosis)
01/2022
1Ectopic Atrial Tachycardia
01/2022
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2022
1Asthma (Bronchial Asthma)
01/2022
1Hodgkin Disease (Hodgkin's Disease)
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022
1Frailty
11/2021
1COVID-19
11/2021
1Multiple Myeloma
11/2020
1Death (Near-Death Experience)
11/2020

Drug/Important Bio-Agent (IBA)

13AnthracyclinesIBA
11/2020 - 02/2012
10Immune Checkpoint InhibitorsIBA
06/2021 - 11/2017
8Antineoplastic Agents (Antineoplastics)IBA
12/2018 - 06/2012
7Biomarkers (Surrogate Marker)IBA
10/2022 - 05/2016
6Trastuzumab (Herceptin)FDA Link
11/2020 - 12/2011
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 06/2012
5nitroxylIBA
02/2022 - 12/2005
4omega-Chloroacetophenone (Mace)IBA
01/2021 - 01/2019
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 04/2013
3Proteasome InhibitorsIBA
11/2020 - 05/2016
3Phosphotransferases (Kinase)IBA
11/2020 - 03/2016
3TroponinIBA
01/2019 - 05/2016
3Natriuretic PeptidesIBA
01/2018 - 05/2016
2Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2022 - 02/2007
2Vasodilator Agents (Vasodilators)IBA
01/2021 - 05/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 06/2016
2Adrenergic Agents (Adrenergic Drugs)IBA
01/2020 - 03/2016
2PalmitatesIBA
01/2020 - 10/2015
2CalciumIBA
01/2018 - 01/2016
2RanolazineFDA Link
01/2018 - 04/2014
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2018 - 04/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 04/2014
2ErbB Receptors (EGF Receptor)IBA
05/2016 - 05/2016
2Growth Factor ReceptorsIBA
05/2016 - 05/2016
2Free RadicalsIBA
05/2016 - 05/2016
2Angiogenesis InhibitorsIBA
05/2016 - 05/2016
2Oxygen (Dioxygen)IBA
01/2016 - 05/2014
2Fatty Acids (Saturated Fatty Acids)IBA
10/2015 - 06/2015
2Insulin (Novolin)FDA Link
10/2015 - 04/2013
2AntioxidantsIBA
04/2013 - 05/2008
2oxyhyponitriteIBA
12/2005 - 01/2005
1KATP ChannelsIBA
02/2022
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2022
1Tetrazolium SaltsIBA
02/2022
1liposomal doxorubicin (Doxil)FDA Link
01/2022
1Adenosine (Adenocard)FDA LinkGeneric
01/2022
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2022
1Mitochondrial Form Creatine KinaseIBA
01/2022
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1Ion Channels (Ion Channel)IBA
01/2022
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2022
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2022
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2022
1atezolizumabIBA
06/2021
1avelumabIBA
06/2021
1durvalumabIBA
06/2021
1cemiplimabIBA
06/2021
1pembrolizumabIBA
06/2021
1IpilimumabIBA
06/2021
1NivolumabIBA
06/2021
1Monoclonal AntibodiesIBA
06/2021
1AndrogensIBA
11/2020
1Immunomodulating AgentsIBA
11/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020

Therapy/Procedure

26Therapeutics
01/2023 - 05/2014
8Drug Therapy (Chemotherapy)
01/2022 - 06/2012
3Immunotherapy
06/2021 - 01/2018
3Aftercare (After-Treatment)
12/2019 - 06/2016
2Transplantation
01/2022 - 01/2018
2Secondary Prevention
05/2016 - 05/2016
1Hand Hygiene
11/2021
1Heart Transplantation (Grafting, Heart)
11/2021